Nanosphere to Present at the Cowen and Company 33rd Annual Health Care Conference

Nanosphere to Present at the Cowen and Company 33rd Annual Health Care 
Conference 
NORTHBROOK, IL -- (Marketwire) -- 02/22/13 --  Nanosphere, Inc.
(NASDAQ: NSPH), a leader in the development and commercialization of
advanced molecular diagnostics systems, today announced that an
overview of the company's business and commercial strategy will be
given by Nanosphere's President and Chief Executive Officer Michael
McGarrity at the Cowen and Company 33rd Annual Health Care
Conference, being held at the Boston Marriott Copley Place in Boston,
Massachusetts. The Company presentation is on Tuesday, March 5 at
11:20am-11:50am Eastern Time. 
A live webcast of Nanosphere's presentation will be available at
www.nanosphere.us. 
About Nanosphere, Inc. 
 Nanosphere develops, manufactures and
markets an advanced molecular diagnostics platform, the Verigene(R)
System, for direct genomic and ultra-sensitive protein detection.
This easy to use and cost effective platform enables simple, low cost
and highly sensitive genomic and protein testing on a single
platform. Nanosphere is based in Northbrook, IL. Additional
information is available at http://www.nanosphere.us. 
Forward Looking Statement - Except for historical information, the
matters discussed in this press release are "forward-looking
statements" and are subject to risks and uncertainties. Actual
results could differ materially from these forward-looking
statements. Factors that could cause or contribute to such
differences include, but are not limited to, the following: (i)
Nanosphere's ability to develop commercially viable products; (ii)
Nanosphere's ability to achieve profitability; (iii) Nanosphere's
ability to produce and market its products; (iv) Nanosphere's ability
to obtain regulatory approval of its products; (v) Nanosphere's
ability to protect its intellectual property; (vi) competition and
alternative technologies; and (vii) Nanosphere's ability to obtain
additional financing to support its operations. Additional risks are
discussed in the Company's current filings with the Securities and
Exchange Commission. Although the Company believes the expectations
reflected in such forward-looking statements are based on reasonable
assumptions, it can give no assurance that its expectations will be
attained. The forward
-looking statements are made as of the date of
this press release, and we undertake no obligation to publicly update
or revise any forward-looking statement, whether as a result of new
information, future events or otherwise. 
CONTACT
Nanosphere, Inc.
Roger Moody
Chief Financial Officer
847-400-9021
rmoody@nanosphere.us 
LifeSci Advisors
Michael Rice 
Founding Partner
646-597-6979
mrice@lifesciadvisors.com